Severe atopic dermatitis drug sees positive study results
Base to Base biotech podcast 50: Drugs for kidney transplants, glycans, and  drug delivery
Anti-cancer drug gets phase I FDA trials approval
New mass spec platform launched
Pfizer injectable shows continued weight loss in phase 2b trial
Skin damage protein ID could lead to new therapies
Origami Therapeutics and Ipsen to advance protein degrader programme
IQVIA and Boehringer Ingelheim announce data collaboration
Next-generation biopreservation for cell therapy
Predicting cancer evolution
Base to Base biotech podcast 45: Chronic pain, urology, Affibody molecules and radioligand therapy
Johnson & Johnson prostate cancer drug receives CHMP positive opinion